**Trustees' Annual Report for the period** ||Period start date|Period start date|||Period end date|Period end date|| |---|---|---|---|---|---|---|---| ||Day|Month|Year||Day|Month|Year| |**From**|1|12|2020|**To**|30|11|2021| Section A Reference and administration details **Charity name** The Soulsby Foundation **Other names charity is known by** none **Registered charity number (if any)** 1174783 **Charity's principal address** 12 Aynsley Court Sandwich **Postcode CT13 9DU** **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15|**Trustee name**|**Office (if any)**|**Dates acted if not**
**for wholeyear**|**Name of person (or body) entitled to**
**appoint trustee(if any)**| |---|---|---|---|---| ||Dr Judy MacArthur
Clark|Chair|Whole period|| ||Dr Babulal Sethia||Wholeperiod|Royal Societyof Medicine| ||Prof David Heymann||Whole period|Royal Society for Tropical Medicine &
Hygiene| ||Lord Trees of the Ross||Wholeperiod|| ||Dr Colin Johnstone||Until July2021|| ||Dr Peter Jinman||Wholeperiod|Royal College of VeterinarySurgeons| ||Dr Jennifer Brazier|Hon. Treasurer|Wholeperiod|| ||Ms Suzanne Jarvis|Hon. Secretary|Wholeperiod|| ||Dr Gabrielle Laing||From Sept 2021|| ||Dr Simon Wheeler||Wholeperiod|| ||Prof Andrew Peters||Wholeperiod|| ||Prof Donald Kelly||Wholeperiod|| |||||| |||||| |||||| ||**Names of the trustees for the charity, if any, (for example, any custodian trustees)**|||| ||**Name**||**Dates acted if not for whole year**|| |||||| |||||| |||||| **Names and addresses of advisers (Optional information)** March **2012** **TAR** 1 |**Type of adviser**
**Name**
**Address**|**Type of adviser**
**Name**
**Address**|**Type of adviser**
**Name**
**Address**| |---|---|---| |**Legal Adviser**|Martyn Robinson|Hewitson’s, 42 Newmarket Rd, Cambridge, CB5 8EP| |**Website adviser**|Tim Green|Dewar Green, St Michaels, Tenterden, Kent, TN30 6PR| |||| |||| ## **Name of chief executive or names of senior staff members (Optional information)** None ## **Section B Structure, governance and management** ## **Description of the charity’s trusts** Type of governing document Constitution - (eg. trust deed, constitution) How the charity is constituted CIO - (eg. trust, association, company) Open advertisement and/or recommendations by Board members and Trustee selection methods others. Final selection by the full Board. In addition, one trustee may be (eg. appointed by, elected by) nominated by each of the Royal College of Veterinary Surgeons (RCVS), the Royal Society of Medicine (RSM) and the Royal Society for Tropical Medicine & Hygiene (RSTMH) in accordance with the Constitution which requires approval of the Board. ## **Additional governance issues (Optional information)** You **may choose** to include additional information, where relevant, about: - policies and procedures adopted for the induction and training of trustees; - the charity’s organisational structure and any wider network with which the charity works; - relationship with any related parties; - trustees’ consideration of major risks and the system and procedures to manage them. The main activity of the Foundation is to appoint Soulsby Traveling Fellows who will carry out approved projects in the general field of One Health internationally. In addition, the Board appoints a current leader in One Health globally to deliver the annual Soulsby Lecture, usually in association with a major conference. Lecturers appointed generally alternate between medical and veterinary health professionals though other related professions may be considered. The Board has defined the policy and criteria for Fellowship, and a written procedure is followed. This has been published on the Foundation’s website as part of openness and transparency, and will remain under review as each appointment cycle takes place. Eligibility for consideration for a Fellowship has been expanded geographically to include affiliation to a relevant academic institution in the UK, EU, Australasia and North America. Fellows must hold a professional qualification in either human medicine or veterinary medicine. One trustee retired during the year having reached the end of their appointment. One new trustee was appointed. The Foundation is formally connected with the RCVS, the RSM and the RSTMH with each organisation having a representative on the Board. Fourteen Soulsby Fellows have so far been appointed and they have now formed a Community of Fellowship to provide advice to the Board as well as to each other. One Fellow, selected by the Community, attends Board meetings as a non-trustee to participate in Board discussions and provide feedback to and from all the Fellows. The daughter of Lord Soulsby continues to be a Patron of the charity. A volunteer non-trustee has been appointed to serve as administrative support to the Board, especially in relation to arranging meetings and preparing reports as well as managing the processes for selecting Fellows. This individual receives a small honorarium. March **2012** **TAR** 2 A formal system to identify any Conflict of Interest in relation to any of the Foundation’s work, including awarding Fellowships, has been put in place and is described on the website. The Board has established a Finance sub-committee chaired by the Hon. Treasurer with three other Trustees and terms of reference have been agreed. An anti-bribery policy has been developed and a system for internal reporting of suspicions has been agreed. ## **Section C Objectives and activities** The objects of the CIO are, for the public benefit, the advancement of science and public health, in particular by promoting research, education, **Summary of the objects of the** healthcare delivery and advocacy around the connections between **charity set out in its** animal and human health and the environment. **governing document** ## **Soulsby Fellowships:** The Board has completed the fourth cycle of advertising for applicants for Fellowships, selection and appointment of four Soulsby Fellows for 2021. The fifth cycle of advertising was started on 1[st] November 2021 with applications being accepted until 31[st] January 2022. The new Fellows will be announced in June 2022. **Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** Soulsby Fellows are required to produce a report of their Fellowship project, and encouraged to make this a public report, either as a presentation or poster at a relevant conference, or as an openly published paper or report. ## **Soulsby Lectures:** - The sixth Soulsby Lecture was delivered in person and to a virtual audience by **Dr Richard Horton, Editor-in-Chief of The Lancet** , in October 2021 as a keynote address at a meeting on One Health held jointly at the Royal Society of Medicine in London between the Soulsby Foundation and the RSM Section for Comparative Medicine. The lecture was open to the public to attend with registration and a recording is available on the Soulsby Foundation website. The Trustees have regard to the guidance issued by the Charity Commission on public benefit in selecting Soulsby Fellows and the topic and delivery of the annual Soulsby Lecture. ## **Additional details of objectives and activities (Optional information)** You **may choose** to include further statements, where relevant, about: - policy on grantmaking; - policy programme related investment; - contribution made by volunteers. The Board has published the following on its website to ensure its policy on grant making is transparent: - The definition of One Health applied by the Trustees in considering applications for Fellowships; - Criteria for Fellowships and the process for applying; - The process followed by the Trustees in selecting Fellows from applications received; - The Foundation’s Conflict of Interest Policy; and - A full list of the Trustees who all serve in a voluntary capacity. March **2012** **TAR** 3 The Board has agreed that expenses of Board members will be reimbursed only exceptionally in order to maximise the impact of donations in the field of One Health. ## Section D Achievements and performance **Summary of the main achievements of the charity during the year** The Foundation has appointed four further Soulsby Fellows for 2021 (in addition to the two inaugural Fellows in 2018, three Fellows in 2019, and five Fellows in 2020). They are: - **Dr Stephanie Brien - Assessing disease risk across a wildlifelivestock interface in Chad** - Endangered antelope are being reintroduced to desert regions to restore lost biodiversity and improve ecosystem function. This brings antelope into contact with livestock, which can result in disease transmission. In these regions, many people are heavily dependent on livestock and are at risk of contracting infections carried by their animals. - This project explores the infection status of livestock and reintroduced antelope in Chad. Dr Brien aims to identify the key disease transmission risks, whilst developing tools for monitoring wildlife-livestock health more broadly. This will enable the identification of management solutions that benefit humans, wildlife and livestock. - • **Dr Olga Calatayud - Identifying and understanding the natural barriers preventing spill over of viruses.** - The research questions addressed in this project were generated in Dr Calatayud’s preliminary study of carnivore parvovirus in the Serengeti, Tanzania. She discovered that this environment is resistant to the introduction of the pandemic variant of carnivore parvovirus which is invading almost all carnivore populations globally except the Serengeti. - `o` The aim is to understand the ecosystem barriers that prevent cross-species in this environment. She will analyse the epidemiology of carnivore parvovirus in a second ecosystem in Kenya to make comparisons. This information is fundamental to understanding the links between ecosystem integrity and the risks of outbreaks in animals and humans. - • **Dr Katherine Laycock - An Initial Assessment of Human Arboviral Infections in Botswana.** `o` The mosquito’s ability to transmit infectious diseases makes this small insect the world’s deadliest animal. As climate change and human movement spread mosquitoes to different regions of the world, mosquito-borne diseases may follow— with potentially devastating consequences for humans and other animals. - `o` Dr Laycock’s research in Botswana aims to determine whether two families of mosquito-borne viruses, or arboviruses, have entered the country to affect people and mosquitoes there. This work, part of the first arboviral research in Botswana in over 50 years, will help build valuable research capacity and provide important guidance for mosquito control programs in Botswana and neighbouring countries. March **2012** **TAR** 4 ## Section D Achievements and performance - **Dr George Oluoch - Developing the Next Generation Snakebite Therapies** - This project aims to study the potential of camel antibodies to develop a new snakebite community-dispensable treatment. Snakebite is a neglected tropical disease that kills more than 100,000 and causes severe tissue damage maiming as many as 400,000 victims, every year, with few or no medicines available. - The project will engage affected communities, healthcare workers and policy makers as well as assess camel antibodies to advise the development of a safe and affordable therapy to treat the disabling health and socioeconomic effects of snakebite in sub-Saharan Africa. All four Fellows are actively pursuing their projects and providing regular reports to the Trustees and blogs for the website. In addition, the Fellows appointed in 2018, 2019 and 2020 are all working actively toward completing their projects. The Trustees are aware that the Covid-19 pandemic has restricted opportunities for travel for many Fellows and has agreed no-cost extensions to Fellowship awards to allow for unavoidable delays. The fifth cycle of advertising for Fellowship applications was started on 1[st] November 2021 with applications being accepted until 31[st] January 2022. The new Fellows will be announced in June 2022. ## **The 2021 Soulsby Lecture:** `o` The sixth Soulsby Lecture was delivered in person and to a virtual audience by **Dr Richard Horton, Editor-in-Chief of The Lancet** , in October 2021 as a keynote address at a meeting on One Health held jointly at the Royal Society of Medicine in London between the Soulsby Foundation and the RSM Section for Comparative Medicine. The lecture was open to the public to attend with registration and a recording is available on the Soulsby Foundation website. ## **Section E Financial review** |**Brief statement of the**
**charity’s policy on reserves**|The Foundation’s policy is to hold sufficient funds in its regular bank
accounts to cover one to two year’s predictable expenditure. This is
building resilience in a young charity and is mostly in a savings account
earning interest.
The remainder of the Foundation’s funds are held in the investment
account of the Royal Society of Medicine who invest the funds on our
behalf in their general investment account overseen by Cazenove
Investment Advisors. This is a relatively low risk account but is
nevertheless vulnerable to market fluctuations as have been experienced
during the 2020-21 financial year.
During 2020, the Trustees appointed a small Finance sub-Committee,
chaired by the Treasurer, to review the Foundation’s investment and
reserves policy. The Committee reports regularly to the Trustees.| |---|---| March **2012** **TAR** 5 **Details of any funds materially in deficit** The Foundation does not have any funds materially in deficit. ## **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: - the charity’s principal sources of funds (including any fundraising); - how expenditure has supported the key objectives of the charity; - investment policy and objectives including any ethical investment policy adopted. The Foundation’s initial funding in 2016 was through a £100K legacy donated by Lord Soulsby. Since achieving charitable status in September 2017, the Trustees have sought additional donations, mainly from friends and colleagues of Lord Soulsby. This has added about £85K to the total. In addition, and based on the number of high-quality applications we have received and the robust selection process we have in place, we have been awarded a grant from the Alborada Trust of £125K over five years (2020-24). - The Trustees awarded a total of £50K in 2018 (two Fellowships) and 2019 (three Fellowships). Since 2020, we have been able to match the Alborada Trust grant and hence award up to £50K per year (four or five Fellowships). We anticipate this will enable us to have a cadre of some 30 Fellows appointed by 2024 who are active in the field of One Health. We anticipate this demonstrated success will enable us to apply for further substantial grants at that stage. The fund-raising strategy and policy of the Foundation is under regular review. Meanwhile, our ethical investment policy is aligned with that of the Royal Society of Medicine which does not permit the holding of investments in any company with tobacco interests. It also does not permit the direct holding of investments whose primary business (more than 10% of group turnover) is in Fossil Fuels, Gambling, Arms or Pornography. In addition, the total value of the funds invested indirectly should not be more than 5% in those areas. ## **Section F Other optional information** None. ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s)** **Full name(s)** Judy MacArthur Clark **Position (eg Secretary, Chair, etc)**[Chair ] **Date** March **2012** **TAR** 6 **Charity Name No (if any) The Soulsby Foundation** ## **Receipts and payments accounts** Period start date Period end date **To** 12/1/2020 11/30/2021 **For the period from** ## **Section A Receipts and payments** **----- Start of picture text -----**
Unrestricted Restricted Endowment
Total funds
funds funds funds
to the nearest
to the nearest £ to the nearest £ to the nearest £
£
A1 Receipts
Contributions to Capitol (small donations) 155 - - 155
Contributions to Capitol (single large dontation) - - - -
Contributions to Capitol (recurring dontations) 28,500 - - 28,500
Transfer from investment account 5,632 - - 5,632
Interest earned 7 - - 7
Gift Aid received - - - -
Return of unspent fellowship grants - - - -
Authors license fee 60 60
- - - -
Sub total (Gross income for AR) 34,354 - - 34,354
A2 Asset and investment sales, (see
table).
- - - -
- - - -
Sub total [ - ] - - -
Total receipts 34,354 - - 34,354
A3 Payments
Fellowship grants awarded 24,624 - - 24,624
Expenses- website license 288 - - 288
Expenses-design costs - - - -
expenses-foreign exchange 48 - - 48
Expesnes-trustees - - - -
expenses Administration costs 1,200 - - 1,200
expenses -Just giving costs - - - -
- - - -
- - - -
Sub total 26,160 - - 26,160
A4 Asset and investment purchases,
(see table)
- - - -
- - - -
Sub total - - - -
Total payments 26,160 - - 26,160
Net of receipts/(payments) 8,194 - - 8,194
A5 Transfers between funds - - - -
A6 Cash funds last year end 57,175 - - 57,175
Cash funds this year end 65,369 - - 65,369
**----- End of picture text -----**
## **Section B Statement of assets and liabilities at the end of the period** ||||**Unrestricted**||**Restricted**| |---|---|---|---|---|---| |**Categories**|**Details**||**funds**||**funds**| |**B1 Cash funds**|HSBC Checking account balance
HSBC Savings account balance
**_Total cash_**|**_funds_**|**to nearest £**
**1,679**
**63,690**
**-**
**65,369**|


|**to nearest £**
**-**
**-**
**-**
**-**| ||(agree balances with receipts and payments
account(s))||OK|OK|| ||||**Unrestricted**||**Restricted**| ||||**funds**||**funds**| |**B2 Other monetary assets**|**Details**||**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**|




|**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**| |**B3 Investment assets**|**Details**
Invested Reserve Funds||**RSM FUND**
**Fund to which**
**asset belongs**|**Cost (optional)**
**-**
**-**
**-**
**-**
**-**|| |**B4 Assets retained for the**|**Details**||**Fund to which**
**asset belongs**|**Cost (optional)**
**-**|| |**charity’s own use**||||






|**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**| ||||**Fund to which**||**Amount due**| |**B5 Liabilities**|**Details**
Grant Payments outstanding 2018
Grant Payments outstanding 2019
Grant Payments outstanding 2020
Grant Payments outstanding 2021|


|Grant awards
Grant awards
Grant awards
Grant awards
**liability relates**|



|**2,145**
**959**
**21,556**
**19,159**
**-**
**(optional)**| |Signed by one or two trustees on behalf of all
th tt|Signature||Print|Name|| Signed by one or two trustees on behalf of all the trustees **----- Start of picture text -----**
CC16a
**----- End of picture text -----**
## **Last year** **to the nearest £ 2,254 - 28,500 - 69 2,756 - 906 100 34,585** **34,585** **24,342 288 171 94 - 1,000 18 - - 25,913** **25,913 8,672 - 48,502 57,174** ## **Endowment funds to nearest £** **-** ## OK ## **Endowment funds to nearest £** **-** **Current value (optional) 65,695 - - - -** **Current value (optional)** **When due (optional) 01 July 2022 01 July 2022 01 July 2022 01 July 2022** Date of approval CHARITY COMMISSION FOR ENGLAND AND WALE5 Independent examiner's report on the accounts Section A Independent Examin&r's Report Report to the trusteesl memb¢r5 of The Soulsby Foundatlon On accounts for the year ended 30 November 2021 Charlty no (If any) 1174783 Set out on pa.ges I report to the trustees on. my examination of the accounts of the above charity Clhe Trusl°I for the year ended 3011112021. Re5pon5ibilities and basls of report. As the charitVs trustees, you are responsible for the preparation of Ihe a(zounts in'accordance wilh the requirement5 of the Charities Acl.2011 {'.Ihe Act"). I report in respect of my ex8minatlon of . the Trust's accounts carried out under sectlDn 145 of the 2011 Act and in carrying out my examinalion. I have followed all the applicable DireGltons given by the Charity Commlssion under section 14515)(b} of the Act. Ind8pendent tthe charity's gT05S income exceeded £250,000 and l am qualified to examiner's statenient urtdertake lh9 8xamin8tDn by belng a qualrfied member of [insert name or applicable Ilsted bodyJ]. Delete l ] If not applicable. I have completed my exaTninatiDn. I confirm that no material matters have come to my attention in conn&clion wth th8 8xaminalion (other Ihan thal disdo$ed below'l which gives me caus8 to believe that in. any material respeGt'. the accounting records were not kept in acGordancB Wvith section 130 of the Charities Act., or the accounts dld not accord wilh the accounlfng ￿OrdS,. or the accounts did not compty with Ihe applicable requirements con￿Ming the form and content of accountsset out in the Charfties (Accounls and Reports) Regulations 2008 other than any requirement that the accounts glve a 'true and fairf view which is not a matter considered as part of an independenl examination. I have no fjoncerns and have come across no other matters in connection wilh the examinatlon to whith attentton should be dra￿ In thls report in order lo enable a proper under5tandlng of the acc()unts to be reached. ' Please delete the words in the brackets if they do not apply. Signed.. Date: )2. 8. Name.. CdERli k Mcc,Y4ts Relevant professional qualrfiGation(s} or body IER Oct 2018 lif any).. Address: IoR- rNrtLJoff kTI O Oov, Section B Disclosure Only complete if Èh8 &xaminer needs lo highlighl materiel matters of concem (see CC32. Independent examlnation of char￿Y accounts.. dlrections and guidance for examlnèrs). Glve here brief details of any items that the examinerwishgs to disclos0. IER Oct 2018 CHARITY COMM15510N FOR ENGLAND AFJD WALES Tho So¢dgty Foundalon Recei Foptho perfod ts ancl ayments aGcounts CC16a 1211120ZI) 1113012021 Section A Receipts and payments Unrestricted Re5triGted funds Endowment fuhds La6ty lotho nvpst tDtheRewex£ tolhe n93￿￿1£ IVlhenemt£ IDlhe newp5t£ Al R8celp18 12¥4 ￿Ca[￿￿1{￿￿g1•I?I[& dOrthak)Thl n￿lI0￿gi 2B.6fj0 S,632 2¥.5UO 28.500 Trdnsferttom inVBstm8niaccouni r95Léam9d 2.756 Retwll Of￿ Mn 06 Sub total (Gross wcorne forAR} A2 AS￿an{l Inv•s¢rn&nt 5ala$, IseA table?. 34,J5d Sub total Total receipts 34J54 A3Pa F8lowsh nisBwartyed enSes-sVgOSfteD￿nsÈ EXp¢n￿1.d*Jlln Cosig èxpÈnges-lllr gi¢han 24,82¢ 284 Z88 48 48 94 en8eSAdMin￿LraboTh¢Qsts 15￿.J￿il￿rid￿o$t9 1200 Sub tolal 26.1fj0 A4 A88et and investmeDtpurclwsè 500 tab Sub lotal 26,46 26,160 +Veè of reGeipts/(pdympntsJ A5Trnn5fBr5 between fund5 A6 Cash funds lastyè2*ènd Cash thnds thls y4ar •nd &194 5T,175 57.17 CCXX R1 accour￿915s) 8112r2w22 Section B Statement of assets and liabilities at the end of the period Vnrestrlct&d Rp$triGtsd Thd$ EndoYfm6ht atègoflg¥ to n¢aMtE noarb5t£ IoN&ioYt£ Bl ¢ash funds H5￿C￿ng awjuniba 1.679 Hs￿sa￿￿95￿¢eL￿lb￿a￿L 63.69& Tol81 cesh funds Unrestri¢1od funds lonoimst£" RestriGted funds to nEa￿SEE Erdowmfrnt lund$ Optails Y2 othor monotsrya￿èts Funt(tOVihkh assetb￿rA1 otaus ID*sWAe5ErYe F￿4$ 83 Invpstrnent assats RSM FUNO FUDdtOYthkh tJ*lbi1s CostloKIIDnoll CtsYiÈnt*lu• B4 Assets retain0d for the charlty's own ￿Se *JhOuntdts ionoi 2,145 Whm duth otalls Yela￿S B5 Liibilitie5 Gra￿E01 01 Juty2022 01 Juty 2022 Gr* PA￿￿l￿(mrtSIJ￿cFny2Dlg fjr￿ PawwL%otsianoYfig2030 21,656 01 July 2022 01July2022 Grartaths 9,159 orlwD irustees cnbehallof ¥Jl thptrustees SKJnature PrlntNamè Dale pf rowal CCX>¢ R2aGCfAmts ISS) all2￿022